Topic: Adenoviral Technology

Dr. Peter McCullough presents a PowerPoint explaining that mRNA and adenoviral vaccines are genetic transfer technologies rather than traditional vaccines. He argues that these shots hijack the body's ribosomes to produce the pathogenic spike protein, which can circulate in the body for over a year. McCullough references research by Bruce Patterson showing the long-term persistence of these proteins in human tissue.

The COVID-19 vaccines utilize genetic transfer technology to trick human ribosomes into producing the pathogenic spike protein originally engineered in a Wuhan lab. Research by Sanjaya Bansal shows that these spike proteins circulate in the body within exosomes for extended periods. Unlike traditional vaccines, these injections bypass the body's natural mucosal defenses in the nose and mouth.